|
2025
|
G/S
|
Medizinische Präparate und Substanzen; Arzneimittel und natürliche Heilmittel; Pharmazeutische Ar... |
|
|
G/S
|
Medicinal preparations and substances; Pharmaceuticals and natural remedies; Pharmaceutical drugs... |
|
|
Invention
|
Orally applicable suspension for the treatment of eosinophilic esophagitis in children. Disclosed... |
|
2024
|
G/S
|
Pharmaceutical preparations for the treatment of the intestinal tract including the esophagus |
|
|
G/S
|
Pharmaceutical preparations for the treatment of the intestinal tract and the liver |
|
2023
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and diseases of the digestive... |
|
|
Invention
|
Anti-cd30l antibodies, formulations therefor, and uses thereof. Described herein are anti-CD30L a... |
|
|
Invention
|
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum.
Disclosed is... |
|
2022
|
Invention
|
Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of inte... |
|
|
Invention
|
Anti-cd30l antibodies and uses thereof. Described herein are anti-CD30L antibodies and pharmaceut... |
|
|
Invention
|
Pharmaceutical composition for the oral administration of poorly soluble drugs comprising an amor... |
|
|
Invention
|
3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitors.
A compou... |
|
|
Invention
|
Orodispersible effervescent tablet comprising budesonide for use in the treatment of eosinophilic... |
|
|
Invention
|
Anti-cd30l antibodies and uses thereof.
Described herein are anti-CD30L antibodies and pharmaceu... |
|
|
Invention
|
Enema for rectal application. Provided is an enema for rectal application containing budesonide a... |
|
2021
|
G/S
|
Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune disease... |
|
|
G/S
|
Pharmaceutical preparations, namely for the domains of gastroenterology and hepatology. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseas... |
|
|
G/S
|
Pharmaceuticals. |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for tg2-related diseases.
The present invention re... |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for coeliac disease.
The present invention relates... |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for tg2-related diseases. The present invention rel... |
|
|
Invention
|
Systemic formulation of a pyridinone derivate for coeliac disease. The present invention relates ... |
|
2020
|
Invention
|
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum. Disclosed is ... |
|
|
Invention
|
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagu... |
|
2019
|
Invention
|
Pellets having a multi-layer structure for delayed release of the active substance in the distal ... |
|
|
Invention
|
3-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitors. A compoun... |
|
|
Invention
|
Method of treating pancreatitis using 1,4-benzoxazine derivatives. The present invention relates ... |
|
2018
|
Invention
|
Use of nor-ursodeoxycholic acid for reducing liver fat. The present invention relates to the use ... |
|
|
Invention
|
3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhib... |
|
2017
|
G/S
|
Intestinal disorder medicine for the treatment of ulcerative colitis. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract |
|
2016
|
Invention
|
Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size. ... |
|
|
Invention
|
Optimized high-dose mesalazine-containing tablet. The present invention relates to an oral enteri... |
|
|
Invention
|
Optimised high-dose mesalazine-containing tablet. The invention relates to an oral gastric-juice ... |
|
|
Invention
|
Pharmaceutical formulation for the treatment of inflammatory changes to the rectum. The invention... |
|
|
Invention
|
3-(6-chloro-3-oxo-3,4-dihydro-(2h)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use ... |
|
2015
|
Invention
|
Enema for rectal application.
Provided is an enema for rectal application containing budesonide ... |
|
2014
|
Invention
|
Pellet formulation for the treatment of the intestinal tract.
An orally administrable pharmaceut... |
|
|
Invention
|
Method of treating ulcerative colitis.
Provided herein are methods of treating and inducing ulce... |
|
|
Invention
|
Method for treating ulcerative colitis.
Provided herein are methods of treating and inducing ulc... |
|
|
Invention
|
Methods of treating ulcerative colitis.
Provided herein are methods of treating and inducing ulc... |
|
2013
|
Invention
|
Pharmaceutical formulation for treating the upper digestive tract.
The invention relates to an e... |
|
|
Invention
|
Pellet formulation for the treatment of the intestinal tract. An orally administrable pharmaceuti... |
|
|
Invention
|
Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate. Embodi... |
|
|
Invention
|
Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate.
Embod... |
